Innovations and challenges in HIV prevention and cure

Discover the latest breakthroughs, challenges, and future directions in HIV prevention and cure in this expert‑led World AIDS Day webinar hosted by ISAC and ISID. This session brings together global leaders in HIV science to explore cutting‑edge research on viral reservoirs, long‑acting prevention tools, and the evolving landscape of HIV control. 🌍 About the Webinar This joint ISAC–ISID World AIDS Day event features two internationally recognised experts who unpack the scientific, clinical, and implementation challenges shaping the next decade of HIV response. 🔬 Advances in HIV Cure Research — Prof. Sharon Lewin Learn about: Novel strategies to target and reduce HIV viral reservoirs Immunotherapeutic approaches including broadly neutralising antibodies (bNAbs) and immune checkpoint blockade Gene‑based therapies such as CRISPR‑Cas9 and vector‑mediated antibody delivery The remaining barriers to scalable, safe, and globally accessible cure strategies 🛡️ Next‑Generation HIV Prevention Tools — Prof. David Lewis Explore: Long‑acting biomedical prevention options, including cabotegravir, lenacapavir, and vaginal rings Evidence from major clinical trials on long‑duration drug delivery Implants, ultra‑long‑acting formulations, and the future of PrEP Key implementation challenges: affordability, resistance monitoring, and equitable access 🧪 Who Should Watch This webinar is ideal for: Infectious disease specialists HIV researchers and clinicians Public health professionals Policy makers and global health advocates Students and trainees in biomedical science 📌 Key Topics Covered HIV cure research Viral reservoir targeting Long‑acting PrEP bNAbs and immunotherapy Gene editing technologies Global HIV implementation challenges World AIDS Day scientific updates 🏛️ About ISAC & ISID The International Society of Antimicrobial Chemotherapy (ISAC) and the International Society for Infectious Diseases (ISID) collaborate to advance global infectious disease research, education, and policy. Disclaimer: Content is for informational purposes only and not a substitute for professional medical advice. 00:00 Start 00:05 Introduction 02:22 Advances in HIV Cure Research: Novel Approaches to Targeting Viral Reservoirs - Prof. Sharon Lewin (The Peter Doherty Institute for Infection and Immunity) 28:51 Next‑Generation Prevention Tools - Prof. David Lewis (University of Sydney / University of Cape Town) 56:55 Q&A Moderators On behalf of ISAC: Prof. David Lye On behalf of ISID: Prof. Eskild Petersen

Managing MDR infections in the ICU: antibiotics, therapy duration and immune modulation
▶︎

Managing MDR infections in the ICU: antibiotics, therapy duration and immune modulation

What's the deal with the Iran deal? | feat. Lt. Col. (Ret.) Jonathan Conricus & Behnam Ben Taleblu
▶︎

What's the deal with the Iran deal? | feat. Lt. Col. (Ret.) Jonathan Conricus & Behnam Ben Taleblu

Human Challenge Studies in Vaccine Development: Expert Insights on AMR | ISAC Webinar
▶︎

Human Challenge Studies in Vaccine Development: Expert Insights on AMR | ISAC Webinar

Optimising antimicrobial therapy in critical care: From Levels to Outcomes
▶︎

Optimising antimicrobial therapy in critical care: From Levels to Outcomes

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

Microsoft Fabric and Power BI - Developer of the Future⚡ [Full Course]
▶︎

Microsoft Fabric and Power BI - Developer of the Future⚡ [Full Course]

AI Talks in Healthcare 9 Webinar - Dr. Nicole F. Roberts, Chirag Patel, Ryan Spitler, Murat Baday
▶︎

AI Talks in Healthcare 9 Webinar - Dr. Nicole F. Roberts, Chirag Patel, Ryan Spitler, Murat Baday

ACLS Drugs Review with Nurse Eunice  📚💉
▶︎

ACLS Drugs Review with Nurse Eunice 📚💉

Tufayl ibn Amr (ra): The Hidden Legend | The Firsts | Dr. Omar Suleiman
▶︎

Tufayl ibn Amr (ra): The Hidden Legend | The Firsts | Dr. Omar Suleiman

Historian Timothy Snyder on ENDING Trump Nightmare FOR GOOD | PoliticsGirl
▶︎

Historian Timothy Snyder on ENDING Trump Nightmare FOR GOOD | PoliticsGirl

L'Iran vuole stritolare Trump. La diretta con Alessandro Orsini
▶︎

L'Iran vuole stritolare Trump. La diretta con Alessandro Orsini

[See You at 12] Closes Higher Despite Re-blockade of Hormuz..."KOSPI to Hit 8,000" | Monday, Apri...
▶︎

[See You at 12] Closes Higher Despite Re-blockade of Hormuz..."KOSPI to Hit 8,000" | Monday, Apri...

Putin's Army Is Running Out Of LOYALTY
▶︎

Putin's Army Is Running Out Of LOYALTY

RL for Agents Workshop - Deep Dive on Training Agents with RL and Open Source
▶︎

RL for Agents Workshop - Deep Dive on Training Agents with RL and Open Source

The Theology of the Holy Spirit Explained and Defended
▶︎

The Theology of the Holy Spirit Explained and Defended

WHO fungal priority pathogens list: challenges in diagnosis and management
▶︎

WHO fungal priority pathogens list: challenges in diagnosis and management

Live Q&A with Brian Greene | World Science Festival
▶︎

Live Q&A with Brian Greene | World Science Festival

My HIV Story
▶︎

My HIV Story

Tackling antimicrobial resistance through a One Health approach: what you need to know
▶︎

Tackling antimicrobial resistance through a One Health approach: what you need to know

You Must Be POOR to Be Saved: The Mark Series pt 37 (10:17-31)
▶︎

You Must Be POOR to Be Saved: The Mark Series pt 37 (10:17-31)